Artigo Revisado por pares

Assessment of futility in clinical trials

2006; Wiley; Volume: 5; Issue: 4 Linguagem: Inglês

10.1002/pst.216

ISSN

1539-1612

Autores

Steven Snapinn, Mon‐Gy Chen, Qi Jiang, Tony Koutsoukos,

Tópico(s)

Advanced Causal Inference Techniques

Resumo

Abstract The term ‘futility’ is used to refer to the inability of a clinical trial to achieve its objectives. In particular, stopping a clinical trial when the interim results suggest that it is unlikely to achieve statistical significance can save resources that could be used on more promising research. There are various approaches that have been proposed to assess futility, including stochastic curtailment, predictive power, predictive probability, and group sequential methods. In this paper, we describe and contrast these approaches, and discuss several issues associated with futility analyses, such as ethical considerations, whether or not type I error can or should be reclaimed, one‐sided vs two‐sided futility rules, and the impact of futility analyses on power. Copyright © 2006 John Wiley & Sons, Ltd.

Referência(s)